Talk:Ellagic acid

This is the talk page for discussing improvements to the Ellagic acid article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.

Alternative medicine

This article is within the scope of WikiProject Alternative medicine, a collaborative effort to improve the coverage of Alternative medicine related articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Alternative medicineWikipedia:WikiProject Alternative medicineTemplate:WikiProject Alternative medicineAlternative medicine articles

Skepticism Mid‑importance

	This article is within the scope of WikiProject Skepticism, a collaborative effort to improve the coverage of science, pseudoscience, pseudohistory and skepticism related articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.SkepticismWikipedia:WikiProject SkepticismTemplate:WikiProject SkepticismSkepticism articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals B‑class Mid‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
B	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Mid	This article has been rated as Mid-importance on the project's importance scale.

biphenyl?

It's a biphenyl (type of polyphenyl) is it not?— Preceding unsigned comment added by Tim (talk • contribs) 21 March 2007 17:21 (UTC)

Cancer research

PMID 25009751 makes the bold claim "EA can act through multiple pathways and can be used as a dietary agent for preventing and treating many common forms of cancer" - whether effectively or not it doesn't say, and seems to imply otherwise later in the conclusion. The article doesn't appear to be MEDLINE indexed. How (if at all) can this be used? Alexbrn ^{talk|contribs|COI} 05:45, 11 August 2014 (UTC)[reply]

authors are ~~not~~ Chinese... not sure they fully control the word "can". The overall thrust of the article, especially the last paragraph, says there are some promising results, but serious problems with ADMET so there is a long long way from where are now to using EA or analogs as a drug. Jytdog (talk) 05:55, 11 August 2014 (UTC) (strike "not" Jytdog (talk) 12:20, 11 August 2014 (UTC))[reply]

Agree - so pretty much in line with our article as it stands in any case. Alexbrn ^{talk|contribs|COI} 06:06, 11 August 2014 (UTC)[reply]

Assessment comment

The comment(s) below were originally left at Talk:Ellagic acid/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.

Hhmmm. Seems to be inconsistent:

(1) "Triphala has three ingredients the third being Emblica officinalis These tannin bearing galls and fruits have more ellagic acid content than the other celebrated sources such as raspberries etc."

(2) "The highest levels of ellagic acid are found in raspberries, strawberries, and pomegranates."

Last edited at 15:56, 14 April 2008 (UTC). Substituted at 14:22, 29 April 2016 (UTC)

Research and health claims - Supplement focus

The current section on “Research and health claims” primarily discusses supplements and cancer-related assertions, often tied to brands with questionable medical claims. However, it’s essential to recognize the broader scientific context.

Ellagic acid, derived from ellagitannins found in fruits and nuts, exhibits antioxidant properties and potential health benefits. The Memorial Sloan Kettering Cancer Center provides a comprehensive page on ellagic acid, referencing peer-reviewed studies. Additionally, NIG and PubChem offer valuable resources. CheckerIsland (talk) 01:49, 18 May 2024 (UTC)[reply]

The "antioxidant properties" exist only in vitro at doses exceeding those of dietary intake, so are just a lab effect. There is no evidence of antioxidant effects in vivo, but rather the likely fate of dietary ellagic acid - as with all polyphenols - is that it is digested into smaller derivatives (which are not possible under current research tools to reliably track in vivo), then rapidly excreted via urine; see also this discussion.

The MSK source under For Health Professionals/Clinical Summary is noteworthy for its absence of discussion about advanced clinical trials, which do not exist. Who would fund multimillion dollar clinical research on a compound that cannot be patent protected for use as an approved drug?

For the encyclopedia, which should represent the mainstream scientific view, there are no reputable WP:MEDRS-quality reviews to add, no changes in international clinical guidelines to recommend ellagic acid for any treatment, and no national regulatory agency supporting any health claims. Zefr (talk) 02:37, 18 May 2024 (UTC)[reply]